Top compounds associated with response to LILRB3


Feature Type Standardized
Nominal ANOVA
mRNA decitabine CTRPv2 pan-cancer AAC -0.051 0.06
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.053 0.06
mRNA BMS-536924 CTRPv2 pan-cancer AAC -0.066 0.06
mRNA BIRB 0796 CTRPv2 pan-cancer AAC 0.07 0.06
mRNA brivanib CTRPv2 pan-cancer AAC -0.066 0.06
mRNA Imatinib CTRPv2 pan-cancer AAC -0.066 0.07
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.07
mRNA PL-DI CTRPv2 pan-cancer AAC 0.056 0.07
mRNA prima-1 CTRPv2 pan-cancer AAC 0.055 0.07
mRNA OSI-027 CTRPv2 pan-cancer AAC 0.062 0.07
Download CSV